Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN112110951A reveals a novel aqueous-phase radical coupling method for Bryostatin C-ring precursors, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Novel nickel-catalyzed route offers high-purity dibenzocycloheptane intermediates with streamlined scalability and reduced environmental impact for global supply chains.
Discover the novel sulfuric acid hydrolysis route for DL-pantolactone in patent CN114773295A. Achieve high purity Vitamin B5 intermediates with reduced wastewater and solvent-free extraction.
Patent CN111087315A reveals a novel aqueous hydrogenation route for Eltrombopag intermediate BPCA, offering superior purity and reduced manufacturing costs for pharmaceutical supply chains.
Patent CN111909089B reveals a high-speed counter-current chromatography method for purifying 950U77, offering superior yield and purity for pharmaceutical quality control.
Patent CN109988090B reveals a green Rh-catalyzed route for tetrahydropyrroles. Offers high diastereoselectivity and mild conditions for pharma intermediates.
Novel Ru-catalyzed route for (S)-duloxetine intermediate offers high ee and yield without nitrogen protection, reducing manufacturing costs.
Novel patent CN106905305A details efficient Empagliflozin synthesis offering supply chain stability and cost reduction for pharmaceutical manufacturing partners globally.
Patent CN119306557A reveals mild two-step synthesis for β-trifluoromethyl enamines. Enables cost reduction and scalable supply for pharmaceutical intermediates.
Novel patent CN117924283A details high-yield spiro compound synthesis offering supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Novel chiral synthesis route for octahydro-2H-pyrrolo[3,4-c]pyridine derivatives offering high purity and scalable pharmaceutical intermediate production capabilities.
Patent CN114149364A reveals a robust Ullmann coupling route for sulfonamide intermediates, offering superior purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN115466255B reveals a high-yield Tropinol synthesis using K5PPdW11O39/C, offering safer alternatives to Raney Nickel for reliable pharmaceutical intermediates supply chains.
Discover the scalable preparation of Compound A for CNS disorders via optimized Sonogashira coupling. Learn about cost reduction in pharmaceutical manufacturing and supply chain advantages.
Novel 4-step route for Elacestrant intermediate. High purity, scalable process for pharmaceutical supply chain cost reduction and efficiency.
Patent CN103992301A reveals iodine-catalyzed chromene synthesis offering cost reduction in pharma intermediate manufacturing and high-purity supply chain reliability.
Patent CN108003156A reveals mild double carbonylation. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN110981823B reveals high-purity triazole synthesis. Achieve significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Advanced synthesis of Ranitidine intermediate via nano-copper catalysis. Eliminates salt byproducts for cost reduction in API manufacturing and high-purity supply.
Patent CN107400036B reveals Rh-catalyzed route for high-purity pharmaceutical intermediates. Enables cost reduction and scalable supply chain for complex chiral compounds.